C3GN and ANCA Vasculitis Scientific Symposium

The C3GN and ANCA Vasculitis Scientific Symposium will bring together nationally recognized experts and multidisciplinary faculty from UCLA to advance clinical understanding, foster collaboration, and lay the foundation for a dedicated, comprehensive program at UCLA focused on these complex and rare kidney diseases.

The symposium will feature leading national experts in ANCA-associated vasculitis and C3 glomerulopathy, alongside UCLA faculty leaders representing relevant specialties, including nephrology, rheumatology, pathology, pulmonology, and other disciplines involved in the diagnosis and management of these conditions. Through expert presentations, multidisciplinary case discussions, and collaborative dialogue, the program will explore advances in disease mechanisms, diagnostic approaches, emerging therapies, and coordinated, patient-centered care.

Beyond education and scientific exchange, a central goal of the symposium is to bring together the expertise and institutional leadership needed to establish a dedicated UCLA program for ANCA vasculitis and C3 glomerulopathy. By engaging nationally recognized faculty and leveraging UCLA’s multidisciplinary strengths, the symposium will help define opportunities for integrated clinical care, research collaboration, innovation, and future program development.

Ultimately, this initiative aims to position UCLA to build a collaborative, specialized program that advances care for patients with these challenging diseases while strengthening opportunities for discovery, education, and national leadership.

Fees 

In-person & Virtual Attendance

• $100 Physicians

• $75 Allied Health Professionals

UC Recharge Payment Information
Registration payment can be submitted via the Interdepartmental or Intercampus recharge system.
For more details, please refer to document here: Recharge Information

Refunds
Cancellations must be received via email to [email protected] by Sunday, November 1, 2026 and will be subject to a $50 processing fee. No refunds will be granted after that date. David Geffen School of Medicine at UCLA reserves the right to cancel or postpone this course if necessary; in the event of cancellation, course fees will be fully refunded to the original form of payment. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties. 

Course Recording
All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the course.

The recorded sessions are not approved for Continuing Education (CE) credit.

1. Recognize the clinical manifestations and diagnostic challenges of ANCA-associated vasculitis and C3 glomerulopathy to facilitate early diagnosis and timely referral.
2. Explain the underlying immunologic and complement-mediated mechanisms of disease and their implications for diagnosis and targeted treatment
3. Evaluate the efficacy, safety, and appropriate clinical use of novel therapies, including complement inhibitors, B-cell-directed therapies, and steroid-sparing treatment approaches.
4. Apply current evidence-based guidelines and emerging clinical trial data to develop individualized treatment strategies for patients with ANCA-associated vasculitis and C3G
5. Integrate multidisciplinary approaches involving nephrology, rheumatology, renal pathology, and transplant medicine to optimize patient outcomes

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The California State Board of Registered Nursing accepts courses approved by the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies. 

Ronald Reagan UCLA Medical Center - Tamkin Auditorium (B-Level)

757 Westwood Plaza
Los Angeles, CA 90095

Parking and Directions
From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on “Structure 8 driveway”. Visitor parking is available in Lot 8 at a rate of $18 for the day. Please use the pay-by-plate stations to purchase your parking permit. The Ronald Reagan UCLA Medical Center is located on the corner of Westwood Plaza and Charles E. Young Dr. South.

Mitigation of Relevant Financial Relationships

The Accreditation Council for Continuing Medical Education (ACCME), Standards for Integrity and Independence mandates that the accreditation manages all identified relevant financial relationship(s) before the program and adequately discloses relationships to learners. The David Geffen School of Medicine at UCLA adheres to the ACCME Standards for Integrity and Independence in accredited continuing education.

The individuals below have been identified as having a position to influence the content of this educational activity. As such, they have disclosed the absence or presence of a relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Daniel Chambers
UCLA

CCPD Staff

Nothing to disclose

Ericka Cunningham, MBA
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

Charles Flippen II, MD, FAAN, FANA
David Geffen School of Medicine at UCLA

CCPD Staff

Nothing to disclose

Yunmi Kim
David Geffen School of Medicine at UCLA

CCPD Staff

Nothing to disclose

Je'Rel Smith, MA
CCPD

CCPD Staff

Nothing to disclose

Kimberly Valencia, CHCP
UCLA David Geffen School of Medicine

CCPD Staff

Nothing to disclose

Timofey Vints, other
UCLA Health

CCPD Staff

Nothing to disclose

Farid Arman, MD, FASN
Physician

Course Director

Advisor-AbbVie (Relationship has ended)|Consulting Fee-Travere (Relationship has ended)|Consulting Fee-Calitidas (Relationship has ended)|Consulting Fee-Otsuka America Pharmaceutical, Inc. (Relationship has ended)|Speakers Bureau-Keenova|Speakers Bureau-Natera

Ramon A Durazo, MD
Physician

Course Director

Nothing to disclose

Mrinalini Sarkar, MD
Physician

Course Director, Faculty

Speakers Bureau-Amgen, Inc.|Speakers Bureau-Novartis Corporation Pharmaceuticals

Lama M Abdelnour, MD, Medical Director of the living donor kidney transplant program

Faculty

Nothing to disclose

Luis Alvarez, MD

Faculty

Augustine Chung, MD

Faculty

Grant or research support-Boehringer Ingelheim Pharmaceuticals, Inc. (Relationship has ended)

Mark Haas, MD, PhD
Cedars-Sinai Medical Center

Faculty

Speakers Bureau-Biogen|Speakers Bureau-Otsuka America Pharmaceutical, Inc.|Paid consultant-argenx|Paid consultant-Novartis Corporation Pharmaceuticals|Paid consultant-Travere|Membership on Advisory Committees or Review Panels, Board Membership-Vera Therapeutics (Relationship has ended)|Paid consultant-AstraZeneca|Paid consultant-Biogen|Paid consultant-Alexion|Grant or research support-argenx

Ramy Hanna, MD

Faculty

Tanaz Kermani, MD

Faculty

Raghu Konanur Venkataram, MD

Faculty

Carla M Nester, MD, MSA, FASN

Faculty

Grant or research support-Novartis Corporation Pharmaceuticals|Grant or research support-Apellis|Advisor-Kira Pharmaceuticals (Relationship has ended)|Grant or research support-Achillion (Relationship has ended)|Grant or research support-Biocryst (Relationship has ended)|Grant or research support-Chemocentryx (Relationship has ended)|Advisor-Molecular Otolaryngology and Renal Research Laboratory (Relationship has ended)|Advisor-Vertex Pharmaceuticals|Advisor-SanegeneBio

Susanne B. Nicholas, MD, Professor of Medicine

Faculty

Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc.|Consulting Fee-Bayer

Niloofar Nobakht, MD

Faculty

Speakers Bureau-Ardelyx|Advisor-Vertex Pharmaceuticals|Speakers Bureau-Caliditas |Advisor-Travere|Advisor-Vera Theraputic |Independent Contractor (included contracted research)-Caliditas|Independent Contractor (included contracted research)-Novartis Corporation Pharmaceuticals|Independent Contractor (included contracted research)-Aurinia (Relationship has ended)|Independent Contractor (included contracted research)-Vertex Pharmaceuticals (Relationship has ended)

Mandana Rastegar, MD

Faculty

Kassem Safa, MD

Faculty

Joanna M Schaenman, MD

Faculty

Grant or research support-Moderna|Grant or research support-Basilea|Grant or research support-Pulmocide|Advisor-OneLegacy|Advisor-MedCure|Grant or research support-F2G (Relationship has ended)

Carl E Schulze, MD

Faculty

Jonathan Zuckerman, MD

Faculty

Juan Vaquerano

Faculty, Other Planning Committee Member

Yaquelin Arevalo Iraheta
Administrator

Other Planning Committee Member

Nothing to disclose

Saturday, November 21, 2026

Registration Process

Step 1) Complete the Exhibitor Letter of Agreement (LOA).

Cancellation/Refund Policy

Please review the terms of the LOA carefully before execution. As specified in the agreement, once executed, your organization is responsible for the full contracted fee associated with the selected exhibit opportunity, even if payment has not yet been submitted. Exhibitor fees are non-refundable, and cancellation or non-attendance does not relieve the organization of any outstanding financial obligation under the executed agreement.

Step 2) New Users: Click here to create account and profile set up.

Step 3) Click "Exhibit at this event" below to make payment.

We hope to have you join us!